Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Dividends payables Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Braskem (BAK) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Braskem (BAK) over the last 14 years, with Q1 2025 value amounting to $1.9 billion.

Braskem's Cash & Equivalents changed N/A to $1.9 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $1.9 billion, marking a year-over-year change of. This contributed to the annual value of $2.6 billion for FY2024, which is N/A changed from last year.
As of Q1 2025, Braskem's Cash & Equivalents stood at $1.9 billion.
Over the past 5 years, Braskem's Cash & Equivalents peaked at $2.7 billion during Q2 2024, and registered a low of $1.9 billion during Q1 2025.